Transcranial Current Loop Stimulation Device

The modular IPG system addresses the drawbacks of traditional DBS by forming a current loop through the scalp and brain, reducing surgical complexity and patient discomfort, and extending battery life, thus enhancing the efficacy of brain stimulation.

JP7578592B2Active Publication Date: 2024-11-06EPIC NEURO INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2021529230
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-07-30
Filing Date
2019-07-29
Publication Date
2024-11-06
Estimated Expiration
2039-07-29

AI Technical Summary

Technical Problem

Traditional deep brain stimulation (DBS) systems are cumbersome, require invasive implant procedures, cause patient discomfort, are prone to infection, and necessitate battery replacement, with complex surgery and long recovery times.

Method used

A modular IPG system is implanted within a burr hole or craniotomy, with synchronized electrical pulses forming a current loop through the scalp and brain, using rechargeable batteries and subcutaneous electrodes to minimize surgical complexity and visibility, and eliminate the need for battery replacement.

Benefits of technology

The system reduces surgical complexity, minimizes patient discomfort, and extends battery life, providing effective brain stimulation with shorter recovery times and improved ease of removal.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578592000001
    Figure 0007578592000001
  • Figure 0007578592000002
    Figure 0007578592000002
  • Figure 0007578592000003
    Figure 0007578592000003
Patent Text Reader

Abstract

A device for providing electrical stimulation to a human brain is described, the device comprising one or more modules, each module comprising an implantable pulse generator (IPG) and a lead with at least one subcranial electrode, the lead extending into or near the surface of the brain. Each modular IPG comprises a battery and a subcutaneous electrode. Each module is inserted into a burr hole, and a seal charges the space to minimize current flow between the subcutaneous and subcranial electrodes.
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] (cross reference) This application claims the benefit of Provisional Patent Application No. 62 / 711,915, filed July 30, 2018 (Attorney Docket No. 51576-705.101), the entire disclosure of which is incorporated herein by reference.

[0002] BACKGROUND OF THE PRESENTINVENTION Electrical brain stimulation has been shown to be a potentially effective treatment for numerous brain disorders, including epilepsy, migraine, fibromyalgia, coma, major depression, stroke rehabilitation, and Parkinson's disease, and is also used in electrocorticography and cortical stimulation mapping (CSM). Traditional deep brain stimulation (DBS) is a neurosurgical procedure that involves the implantation of an implantable pulse generator (IPG) that is placed under the skin near the clavicle. The IPG is battery-powered and delivers electrical pulses through leads that are routed under the skin to an area near the top of the patient's head, where the leads separate into two leads, each with a unique set of electrodes near its tip. The leads are advanced through the skull via two burr holes and implanted such that the target area is between the two electrodes. Deep brain stimulation has been approved by the FDA for the treatment of essential tremor, Parkinson's disease, dystonia, obsessive-compulsive disorder, and epilepsy.

[0003] Traditional DBS systems have disadvantages for the patient and the physician: Implant procedures tend to be hours in duration and involve long recovery times; Tunneled leads cause significant pain and discomfort to the patient; IPGs require pocket incisions that are prone to infection; The IPG itself is susceptible to "rotation factors," where the patient roughly handles the IPG on the chest; IPGs can be visible and unsightly in the chest; The device is very difficult to remove; IPGs must be replaced periodically due to battery depletion; While the issue of replacing IPGs can be avoided by having rechargeable batteries, other drawbacks remain problematic.

[0004] It may be advantageous to have DBS without an IPG implanted in the chest with a tunneled lead. Instead, one may create a modular IPG, which is implanted in the space inside a burr hole in the patient's head, with leads that extend on or into the brain, and subcutaneous electrodes. If two modular IPGs are implanted near each other, the electrical pulses from the two IPGs may be synchronized, thereby creating a current loop where the pulses add up and go through one modular IPG, the brain target, the other modular IPG, and then back through the scalp to the first modular IPG. Such a system may have some advantages over existing DBS technology in that the IPGs can be smaller (since two of the IPGs share the load) and the surgery is simpler without tunneled leads and pocket incisions. Recovery time is shorter. The device is much more easily removable and not visible to the patient. If the IPG has a rechargeable battery, no battery replacement is required. Summary of the Invention [Means for solving the problem]

[0005] BRIEF SUMMARY OF THE PRESENTINVENTION In a broad aspect, the invention provides electrical stimulation to a human brain, the device comprising a first module and a second module, each module comprising: (a) a case; (b) a seal; (c) a battery; (d) a lead having at least one subcranial electrode; (e) a subcutaneous electrode; and (f) a control circuit implementing control logic, the battery and control circuit being contained inside the case and configured to generate electrical pulses at a pulse frequency, pulse amplitude, pulse width, and duty cycle, the case being configured to occupy a space within a burr hole or craniotomy in the skull, the leads being configured to extend near or into the brain, the subcutaneous electrode being configured to be above the skull and below the scalp, and the seal being configured to fill a gap between the case and an edge of the burr hole or craniotomy to minimize current flow between the at least one subcranial electrode and the subcutaneous electrode.

[0006] The two modules can be implanted through a burr hole or craniotomy, and the electrical pulses from each module are synchronized to provide additive stimulation. In one aspect, the modules are each implanted through a burr hole or craniotomy in the skull, and a control circuit with programmed logic in each module is configured to synchronize the electrical pulses between the modules, whereby the electrical current forms a loop, and the loop allows the electrical current to flow inside and outside the skull through at least one stimulation target.

[0007] The batteries may be rechargeable, which may eliminate the need for surgical battery or module replacement. The batteries may be selected to provide sufficient power to ensure stimulation for days, weeks, or months, allowing one to recharge the batteries of each module during regular visits to a clinician. In one aspect, the batteries are rechargeable and each module further comprises a coil and a recharging circuit configured to recharge the battery through magnetic inductive coupling with an external magnetic field generator.

[0008] The first and second modules are kept separate, forming a current loop that includes the brain and the scalp. However, a wire may be used to connect the subcutaneous electrodes of the modules together, which may eliminate the impedance contribution from the scalp. This may reduce the voltage required of the modules and improve their lifespan. However, the wire may involve tunnel wires, which increases the complexity of the procedure and potential side effects. In one aspect, the device further comprises a wire that connects the subcutaneous electrodes of the first and second modules together. In this case, the subcutaneous electrodes do not need to directly contact the scalp tissue, which allows for one continuous shielded current path under the scalp from one module to the other.

[0009] Each modular lead includes one or more electrodes. It is important to ensure effective stimulation where the diseased brain region is accurately targeted. In some instances, the surgeon does not know the optimal stimulation location. Therefore, it is often advantageous to include multiple electrodes in each lead and allow the clinician to identify one or more active electrodes in each lead to effectively target selected regions and result in improved physiological or psychological health of the brain. In one aspect, the control circuitry having programmed logic is further configured to select one or more of the multiple subcranial electrodes to be active.

[0010] When a module of the device is implanted, it may be necessary to inform a person, clinician, or caregiver of information regarding the device. In one aspect, the first module further comprises a speaker configured to provide audio information to the person, clinician, or caregiver. The type of information may include device status and programming parameters. In one aspect, the audio information comprises battery level, pulse frequency, pulse amplitude, pulse width, duty cycle, active electrodes of the first module, active electrodes of the second module, charging status, and treatment status. The audio information may use a speaker or a piezoelectric crystal. The format of the audio signal may take a variety of forms. In one aspect, the audio information is generated as a series of beeps, ticks, or tones that can be decoded.

[0011] In order for information to pass from the programmer to the device or from the device to the programmer, it may be necessary for the device to include an antenna. In one aspect, each module further comprises an antenna, which may receive data from or transmit data to an external programmer. The programmer may be used, for example, to program treatment parameters, initiate therapy, terminate therapy, synchronize stimulation pulses, or request information from the device. In one aspect, the control logic of each module is configured to program treatment parameters of the module based on commands from the external programmer, the treatment parameters comprising active electrode selection, pulse frequency, pulse amplitude, pulse width, duty cycle, therapy start, and therapy stop. In one aspect, the control logic of each module is configured to provide information to the external programmer, the information comprising battery level, pulse frequency, pulse amplitude, pulse width, duty cycle, active electrodes of the first module, active electrodes of the second module, charging status, and therapy status.

[0012] In addition to stimulation, it may be necessary to record an electroencephalogram (EEG) of the person's brain. The EEG data may be used by a control circuit having programmed logic to adjust stimulation parameters. The EEG data may also be transmitted to an external programmer for analysis or diagnosis. In one aspect, the device further comprises an EEG amplifier and an analog-to-digital converter that enable the device to record the person's EEG. A storage memory may be incorporated within the device to store the EEG for use or transmission. In one aspect, the device further comprises a memory configured to store the person's EEG and a transmitting antenna, and the control circuit having programmed logic transmits the stored EEG through the transmitting antenna.

[0013] It may be necessary to initiate activity within the device without the use of an external programmer. One means for doing this is to use an external permanent magnet that activates a magnetic switch within the device when the permanent magnet comes in proximity to the scalp near the module. For example, an external permanent magnet may be used to start, stop, or end EEG recording, or to start or stop stimulation. In one aspect, the device further comprises a magnetic switch, and starting or stopping EEG recording is controlled by a person placing a permanent magnet in proximity to the magnetic switch, or by a person moving the permanent magnet away from the magnetic switch. In one aspect, the device further comprises a magnetic switch, and starting or stopping stimulation is controlled by a person placing a permanent magnet in proximity to the magnetic switch, or by a person moving the permanent magnet away from the magnetic switch. Such a permanent magnet may be carried in a person's pocket for use when required.

[0014] Positioning the electrodes of the device to target specific surface areas of the person's brain allows for the treatment of mental disorders and improves the person's physiological or psychological condition. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the anterior nucleus of the thalamus, which allows for the treatment of epilepsy. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the nucleus accumbens, which allows for the treatment of addiction, such as with alcohol or opioids. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the subthalamic nucleus or the internal pallidal segment, which allows for the treatment of Parkinson's disease or other movement disorders. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the hippocampus, which allows for the treatment of depression or epilepsy. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the subcallosal cingulate gyrus, which allows for the treatment of depression. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the anterior nucleus of the pituitary gland, which may stimulate hormone production. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the midbrain reticular formation or non-specific thalamic nuclei, which allows for the treatment of persistent vegetative state or coma. In one aspect, the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the cortex. Stimulation of cortical targets may help treat a variety of disorders, including depression, anxiety, post-traumatic stress disorder, autism, brain trauma, and stroke. The present invention provides, for example, the following items. (Item 1) A device for electrical stimulation of the human brain, said device comprising: a case configured to occupy a space within a burr hole or craniotomy in the skull; a subcutaneous electrode on the case configured to be above the skull and below the scalp; a lead attached to an underside of the case and configured to be implanted through the burr hole or craniotomy in the person's skull; at least one subcranial electrode, the at least one subcranial electrode being positioned at a lower end of the lead such that when the lead is implanted through the burr hole or craniotomy, the at least one subcranial electrode is positioned at a target location within the patient's brain; a seal on an underside of the case, the seal configured to fill a gap between the underside of the case and an edge of the burr hole or craniotomy and to minimize current flow between at least one subcranial electrode and the subcutaneous electrode; a battery within the case; a control circuit within the case configured to receive electrical current from the battery and generate electrical pulses at a selected pulse frequency, pulse amplitude, pulse width and duty cycle to stimulate the patient's brain; A device comprising: (Item 2) 2. The device of claim 1, wherein the battery is rechargeable and each module further comprises a coil and a recharging circuit, the coil and the recharging circuit configured to recharge the battery through magnetic inductive coupling with an external magnetic field generator. (Item 3) 2. The device of claim 1, wherein the control circuitry is further configured to select one or more of the plurality of subcranial electrodes to be active. (Item 4) 2. The device of claim 1, further comprising an antenna for receiving data from or transmitting data to an external programmer. (Item 5) 5. The device of claim 4, wherein the control circuitry is further configured to program treatment parameters of the module based on commands from the external programmer, the treatment parameters being selected from the group consisting of active electrode selection, pulse frequency, pulse amplitude, pulse width, duty cycle, start of therapy, and stop of therapy. (Item 6) 2. The device of claim 1, further comprising an EEG amplifier and an analog-to-digital converter, enabling the device to record an EEG of the person. (Item 7) 2. The device of claim 1, further comprising a memory configured to store the EEG of the person and a transmitting antenna, the control circuitry transmitting the stored EEG through the transmitting antenna. (Item 8) Item 1, the device further comprising a magnetic switch, and starting or stopping EEG recording is controlled by the person placing a permanent magnet in the vicinity of the magnetic switch or by the person moving the permanent magnet away from the magnetic switch. (Item 9) Item 1 , further comprising a magnetic switch, wherein starting or stopping of stimulation is controlled by the person placing a permanent magnet in proximity to the magnetic switch or by the person moving the permanent magnet away from the magnetic switch. (Item 10) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are within or near the anterior nuclei of the thalamus. (Item 11) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are within or near the nucleus accumbens. (Item 12) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the subthalamic nucleus or the interna pallidum. (Item 13) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are within or near the hippocampus. (Item 14) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are within or near the subcallosal cingulate gyrus. (Item 15) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are within or near the anterior nucleus of the pituitary gland. (Item 16) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the midbrain reticular formation or nonspecific thalamic nuclei. (Item 17) 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are intracortical or near the cortex. (Item 18) A system comprising a first device and a second device, both devices being the devices described in item 1. (Item 19) 20. The system of claim 18, wherein the control circuitry comprises circuitry in each device configured to synchronize electrical pulses between the devices, whereby current forms a loop, the loop allowing current to flow inside and outside the skull through at least one stimulation target. (Item 20) 20. The system of claim 18, further comprising a conductor connecting the subcutaneous electrodes of the first device and the second device together. (Item 21) 20. The system of claim 18, wherein the first device further comprises a speaker configured to provide acoustic information to the person, clinician, or caregiver. (Item 22) 22. The system of claim 21, wherein the acoustic information is generated as a series of beeps, ticks, or tones that can be decoded. [Brief description of the drawings]

[0015] BRIEF DESCRIPTION OF THE DRAWINGS [Figure 1] FIG. 1 is a drawing of one side of the device, showing the case, subcutaneous electrodes, a coil with leads extending from the case, and four selectable electrodes near the distal ends of the leads.

[0016] [Diagram 2] Figure 2 is a drawing of one side of the device, showing a brain implanted with the two modules of the device, the IPG case flush with the skull, and the subcutaneous electrodes and coils under the scalp. The leads of both modules extend into the brain, with lead lengths and electrode placement selected to affect target regions within the brain.

[0017] [Diagram 3] 3 is an electrical schematic diagram of one side of the device, showing the current loops for the two modules of the device, with the electrical pulse generators of the two modules synchronized. The drawing also shows all impedance elements in the current paths.

[0018] [Figure 4] 4 is a diagram showing an example of a charger that is contained within a headband worn by the patient. The charger may also function as a programmer. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Detailed Description of the Invention While specific embodiments have been provided and described herein, it will be readily apparent to those skilled in the art that such embodiments are provided by way of example only. It should be understood that various alternatives to the embodiments described herein may be employed and are part of the invention described herein.

[0020] A device is provided herein that applies electrical current stimulation to a person's brain through implantation of one or more modules through a burr hole or craniotomy in the person's skull. Each module can be divided into two main units: an implantable pulse generator (IPG) and a lead. The IPG is contained inside or on a case and placed into a burr hole or craniotomy that approximately matches the size of the IPG case and positioned so that the top of the IPG is approximately flush with the outer surface of the skull. The IPG comprises a battery, a control circuit with programmed logic, and a subcutaneous electrode. The primary function of the IPG is to generate electrical pulses of a specific frequency, amplitude, pulse width, and duty cycle to provide electrical current stimulation of a target in or on the brain. The lead extends from the IPG and comprises one or more subcranial electrodes at or near the distal end of the lead. The length of the lead and the number and location of the subcranial electrodes along the lead are selected such that one or more of the electrodes are at or near a target area in the person's brain. A control circuit with programmed logic within the IPG selects one or more electrodes to be active and the remaining electrodes to be inactive and not provide a path for current flow. A seal may be positioned to fill the gap between the edges of the IPG and the edges of the burr hole or craniotomy. The seal is intended to minimize or prevent current flow between the subcutaneous electrodes and the active subcranial electrodes.

[0021] If a single module is implanted in a person, a second burr hole or craniotomy may be drilled through the skull to provide a return path for current flow between the subcutaneous electrode and the active subcranial electrode. Alternatively, a purposeful gap may be left between the IPG and the burr hole or craniotomy to allow a return path for the current. When a current pulse is generated in the IPG, a current loop is formed that flows through the lead to the active electrode or electrodes, into the brain, through the target area or areas, through the second burr hole or craniotomy, through the scalp, and back through the subcutaneous electrode to the IPG.

[0022] Alternatively, a control circuit with programmed logic in the IPG may select two electrodes in the lead to be active and provide stimulation between the two active electrodes, without a subcutaneous electrode, in which case a second burr hole or seal may not be necessary.

[0023] The first module and the second module can each be implanted in a person through a unique burr hole or craniotomy, in which case the current pulses from the IPGs in the two modules can be synchronized so that the resulting voltages are additive, which forms a current loop that flows through the lead of the first module to one or more active electrodes of the lead of the first module, into the brain through one or more target regions, through one or more active electrodes of the lead of the second module, through the IPG and subcutaneous electrodes of the second module, through the scalp, through the subcutaneous electrodes of the first module, and back to the IPG of the first module.

[0024] When two modules are implanted, both modules may alternatively occupy the same burr hole or craniotomy. In this case, the subcutaneous electrodes of each module may be connected together, eliminating any substantial current flow through the scalp. When the two electrodes are implanted in separate burr holes or craniotomy, the electrodes may be connected by wires, also eliminating any substantial current flow through the scalp. In this case, the subcutaneous electrodes do not need to directly contact the scalp tissue, which allows for one continuous, shielded current path under the scalp from one module to the other. This has the advantage of lowering the overall impedance through the current path, reducing the chance that the current through the scalp can be sensed by a person. However, wires must be tunneled from one module to the next, which entails additional surgery and possible complications.

[0025] The lead length and electrode location for each module are configured to best provide electrical current stimulation to the target area. In addition, stimulation parameters including pulse frequency, pulse amplitude, pulse width, and duty cycle may be selected based on the indication. For example, stimulation of the anterior nucleus of the thalamus with stimulation set at 5V, 145 pulses per second, 90 microsecond pulse width, and a duty cycle of 1 minute on and 4 minutes off has been shown to be an effective treatment for epilepsy. In another example, stimulation of the nucleus accumbens with stimulation set at 3.5V, 130 pulses per second, and 90 microsecond pulse width has been shown to benefit patients with additions such as opioids or alcohol. Many studies have been conducted using electrical stimulation to treat Parkinson's disease. Generally, stimulation of the subthalamic nucleus or globus pallidus interna with stimulation set at 2.4-4.4V, frequencies in the range of 143-173 pulses per second, and pulse widths in the range of 67-138 microseconds has been found to effectively control locomotor syndromes. Stimulation of the subgeniculate cortex, subcallosal cingulate cortex, ventral internal capsule or ventral striatum, nucleus accumbens, or medial forebrain bundle with various treatment parameters has shown efficacy for treating major depressive disorder (MDD). Stimulation of the ventral internal capsule or ventral striatum, subthalamic nucleus, or inferior thalamic peduncle with various treatment parameters has shown efficacy for treating obsessive-compulsive disorder (OCD). Stimulation of the midbrain reticular formation or nonspecific thalamic nuclei has shown to improve symptoms or coma in patients in a persistent vegetative state.

[0026] In one aspect, the device allows for recharging of the battery of each module. The IPG may further comprise a coil that allows for inductive coupling with an external magnetic field source and a charging circuit that may recharge the battery within the IPG. Recharging may be performed at regular intervals. For example, if stimulation is provided by each module with an impedance of 1000 ohms at 5V, 145 pulses per second, a pulse width of 90 microseconds, and a duty cycle of 1 minute on and 4 minutes off for each module, and the battery has a capacitance of 120 milliamp hours, stimulation may be provided for more than 300 days before the battery is depleted. In this example, recharging every 3 to 6 months works to maintain the functionality of the device. The external magnetic field generator is maintained in the clinician's office, and the patient may recharge the device during regular office visits.

[0027] Other methods of recharging the battery may be used. In one example, ultrasonic charging may be accomplished using piezoelectric crystals within the IPG. Another example is solar recharging using solar cells within the IPG. In this case, the skull is ideal for the location of the IPG since the scalp is relatively thin and generally uncovered except for hair. The person recharges the device by exposing their head to light. Another example is recharging due to natural body movement. Another example is recharging due to temperature differences between subcutaneous and subcranial locations within the IPG.

[0028] It is important that the IPG be implanted flush within the burr hole or craniotomy and that the leads be oriented toward the desired location to provide proper stimulation to the target. Thus, in one aspect, the leads are bendable at the proximal end to the IPG or bendable along the lead itself.

[0029] To control the modules, an external programmer may be required to write data to each module. The data may include treatment parameters such as pulse amplitude, pulse frequency, pulse width, duty cycle, active electrode selection, start therapy, and stop therapy. In one aspect, the IPG further includes an antenna and receiver that receives data from the programmer and passes the data to a control circuit having programmed logic. Examples include Bluetooth and wi-fi modules, or magnetic coupling. It is also possible to use the same coil as that used to recharge the battery. In one aspect, frequency modulation is used to pass data to the IPG. In one aspect, amplitude modulation is used to pass data to the IPG.

[0030] Other means for the programmer to pass data to the IPG are also possible. For example, the IPG may incorporate an amplifier and an analog-to-digital converter, and a control circuit with programmed logic may be configured to recognize an electrical signal detected between two or more electrodes. The programmer may use electrodes on the person's skin to generate low level pulses that cannot be felt but can be detected by a control circuit with programmed logic in the IPG through receiving electrodes.

[0031] Because multiple modules may be implanted within a person, it may be necessary to program the IPGs individually or collectively. To do this, in one aspect, the control circuitry with the programmed logic of each IPG has a unique identifier, and the programmer identifies to which module or modules a particular piece of data or command is directed.

[0032] It may also be necessary for the module to send data to the programmer. Such data may include battery level, pulse frequency, pulse amplitude, pulse width, duty cycle, charge state, therapy delivery state, active electrode(s). This data may be transmitted via a dedicated antenna. Examples include Bluetooth and wi-fi modules, or magnetic coupling. It is also possible to transmit data back to the programmer using the same coil used to charge the battery.

[0033] It may also be necessary to pass information directly to a person without the use of a programmer. For example, if the battery level drops below a threshold, the IPG may generate a beep, click, or tone through a speaker to notify the person. Another means by which the IPG may pass information directly to a person is through the use of a vibration unit. Even with the device implanted, the person should be able to detect the beep, click, or tone due to the generally high sound conductivity of the body. Vibrations should also be able to be felt due to the IPG's proximity to the inner ear.

[0034] When charging, it may be necessary to inform the person that the battery is at or near full charge. This may be accomplished, for example, by generating beeps, clicks, tones, or vibrations. It may also be possible for the IPG to encode information to the person using varying frequency beeps, clicks, tones, or varying vibrations. For example, a low tone followed by a high tone may indicate that the battery is at or near full charge, whereas a high tone followed by a low tone may indicate that the battery is nearly depleted. The IPG encodes more complex information using beeps, clicks, tones, or vibrations. For example, to identify which electrodes are active, the IPG may emit two high tone sounds followed by a click or beep to indicate which electrodes in the module are active and which are not.

[0035] In one aspect of the device, the EEG is recorded by the IPG. In this case, each module may further comprise a memory for storing the EEG. The module may use a dedicated antenna or coil itself to transmit the stored EEG data to the programmer. In this case, the programmer may issue a command for the module to transmit the stored EEG. When such a command is given, a control circuit with programmed logic may transmit the EEG data to an external programmer, for example in a serial manner. The programmer may then issue a command for the module to clear the memory for additional EEG recording. The EEG recording may begin as a result of a command from the programmer, at a predefined interval, or as a result of a specific event. One way that the EEG recording may be initiated is by a person or caregiver holding a permanent magnet close to the module. In this case, the module may further comprise a magnetic switch. When the magnetic switch is activated, the EEG recording may begin. The recording may end after a specific duration, when a command is given by the programmer, or when the permanent magnet is moved closer to or farther away from the module. The magnetic switch may also be used by a person to pause or start therapy independent of recording an EEG.

[0036] Referring to FIG. 1, a diagram presenting certain aspects of the device is shown. The IPG comprises a case (103) that comprises a battery and a control circuit having programmed logic. If EEG is performed, the IPG further comprises an EEG amplifier and an analog-to-digital converter. The IPG further comprises a subcutaneous electrode (102) and a coil (101) that are used to recharge the battery. Leads (104) extend from the IPG. Four electrodes (105, 106, 107, 108) are located near the distal end of the leads. The length of the leads is selected to ensure that one or more of the electrodes are at or near the area of ​​the brain targeted for stimulation. The IPG is implanted in a burr hole in the skull, preferably so that the top surface of the IPG is approximately flush with the top of the skull and the bottom surface of the IPG is approximately flush with the bottom of the skull. This aspect shows four electrodes, but fewer electrodes may be used to minimize complexity and cost, or more electrodes may be used to provide more options. If EEG is being recorded by the device, any two electrodes may be selected for EEG recording, and the EEG recording electrodes may or may not be the same as the electrodes used for stimulation.

[0037] Referring to FIG. 2, a diagram presenting a typical application of the device is shown, where two modules are implanted. The two-module IPG is implanted such that the two modules are approximately flush with the skull (212). The IPG comprises a case (203, 208), subcutaneous electrodes (204, 207) and coils (205, 206). The coils are beneath the scalp (211) and should not be noticed, although they may result in a slight protuberance on the scalp surface. Leads (202, 209) extend from each IPG into the brain (213) and comprise a number of electrodes. An active electrode (201, 210) is selected from each lead to provide stimulation to a target region (214) in the brain.

[0038] Referring to Figure 3, an electrical schematic is shown that models synchronized pulses between two modules of a device. A first module (301) generates a negative pulse. For example, the pulse amplitude is -5V and the pulse width is 90 microseconds. At approximately the same time, a second module (305) generates a positive pulse. For example, the pulse amplitude can be 5V and the pulse width is 90 microseconds. The voltages of the two devices are summed to create a 10V, 90 microsecond pulse. This forms a current loop that passes through the first module (301), the interface between the active electrode of the first module and the brain tissue (308), the brain tissue (307) containing the target area, the interface between the active electrode of the second module and the brain tissue (306), the second module (305), the interface between the subcutaneous electrode of the second module and the scalp (308), the scalp (303) between the two subcutaneous electrodes, the interface between the subcutaneous electrode of the first module and the scalp (302), and back to the first module (301). In general, the impedance between the electrodes and the surrounding brain or scalp tissue is about 500 ohms. The impedance of the brain and scalp in the target area is very small. Thus, the impedance of the entire system is about 2000 ohms. At a synchronized pulse of 10V, the current flow is about 5 milliamps. When the electrodes are connected by wires, the impedance contribution from the subcutaneous electrodes and the scalp (302, 303, 304) can be effectively eliminated, which can approximately double the current flow through the target region in the brain.

[0039] To synchronize pulses between modules, it may be necessary for the two to communicate. This may be done, for example, using a master-slave relationship. The first module may generate a very short, low amplitude pulse at a predetermined time before the therapeutic pulse is delivered. This may be detected by the second module and sent to an amplifier and analog-to-digital converter, either through the coil or through the electrodes, and the second module may be able to generate a pulse synchronized with the first module. Alternatively, the second module may monitor when the first module begins its therapeutic pulse and adjust its timing, so that all pulses are aligned. Alternatively, the timing may be established through an external programmer, where the devices are synchronized and each module is equipped with a clock or timing mechanism accurate enough to keep the two modules synchronized. In this case, the modules may be resynchronized using the external programmer during the clinic visit.

[0040] Referring to FIG. 4, a diagram presenting an exemplary charger is shown. A headband (405) is worn on a person's head (403) such that a charging coil (401) is positioned on or near a first implantable module. A separate charging coil is also positioned on or near a second implantable module. In this example, a battery 402 is included within the headband, which allows charging to occur without the person being tethered to an external power source. A charging port (403) may be included to allow recharging of the charger's battery. It is not required that the charger be a headband. Instead, the charger may be a wearable headset, a hat, or any means by which the charging coil is securely positioned on or near the implantable module. The charger does not even need to be worn. Instead, the charging coil may be part of a cradle that is positioned near the implantable module.

Claims

1. A device for electrical stimulation of the human brain, said device comprising: It has one or two modules, each module having: a case configured to occupy a space within a burr hole or craniotomy in the skull; a subcutaneous electrode on the case configured to be above the skull and below the scalp; a lead attached to an underside of the case and configured to be implanted through the burr hole or craniotomy in the person's skull; at least one subcranial electrode, the at least one subcranial electrode being positioned at a lower end of the lead such that when the lead is implanted through the burr hole or craniotomy, the at least one subcranial electrode is positioned at a target location within the patient's brain; a seal on an underside of the case, the seal configured to fill a gap between the case and an edge of the burr hole or craniotomy; and a battery within the case; a control circuit within the case configured to receive electrical current from the battery and generate electrical pulses at a selected pulse frequency, pulse amplitude, pulse width and duty cycle to stimulate the patient's brain; the subcutaneous electrodes, the at least one subcranial electrode, and the control circuitry of the one or two modules are electrically connected to each other such that, when the electrical pulse is generated, a current loop is formed, the current loop passing from the control circuitry through the lead to the at least one subcranial electrode, into at least the patient's brain, and through the subcutaneous electrode.

2. 10. The device of claim 1, wherein the battery is rechargeable, and each of the modules further comprises a coil and a recharging circuit, the coil and the recharging circuit configured to recharge the battery through magnetic inductive coupling with an external magnetic field generator.

3. The device of claim 1 , wherein the control circuitry is further configured to select one or more of a plurality of subcranial electrodes to be active.

4. 10. The device of claim 1, further comprising an antenna, the antenna capable of receiving data from or transmitting data to an external programmer.

5. 5. The device of claim 4, wherein the control circuitry is further configured to program treatment parameters of each module based on commands from the external programmer, the treatment parameters being selected from the group consisting of active electrode selection, pulse frequency, pulse amplitude, pulse width, duty cycle, start of therapy, and stop of therapy.

6. 10. The device of claim 1, further comprising an EEG amplifier and an analog-to-digital converter, enabling the device to record an EEG of the person.

7. 7. The device of claim 6, further comprising a memory configured to store the EEG of the person and a transmitting antenna, wherein the control circuitry transmits the stored EEG through the transmitting antenna.

8. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are in or near the anterior nucleus of the thalamus.

9. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are in or near the nucleus accumbens.

10. 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the subthalamic nucleus or the interna pallidum.

11. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are within or near the hippocampus.

12. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are in or near the subcallosal cingulate gyrus.

13. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are in or near the anterior nucleus of the pituitary gland.

14. 2. The device of claim 1, wherein the leads of each module are configured to be implanted such that one or more of the subcranial electrodes are in or near the midbrain reticular formation or nonspecific thalamic nuclei.

15. 10. The device of claim 1, wherein the lead of each module is configured to be implanted such that one or more of the subcranial electrodes are intracortical or near cortical.

16. The device described in claim 1, wherein the one or two modules comprise a first module and a second module.

17. The device described in claim 16, wherein the control circuitry of each module comprises circuitry in each device configured to synchronize the electrical pulses between the first module and the second module.

18. 17. The device of claim 16, further comprising a conductor connecting the subcutaneous electrodes of the first and second modules together.

19. 17. The device of claim 16, wherein the first module further comprises a speaker configured to provide acoustic information to the person, clinician, or caregiver.

20. 20. The device of claim 19, wherein the acoustic information is generated as a series of beeps, ticks, or tones that can be decoded.

Citation Information

Patent Citations

  • Anchoring system for securing intracranial catheter or lead wire to patient's skull

    JP2009153974A

  • Leadless nerve stimulation device

    JP2017525545A

  • Satellite therapy delivery system for brain neuromodulation

    US20100125312A1

  • Electrode selection for electrical stimulation therapy

    US20160144186A1

  • System and Method for Transcranial Current Loop Brain Stimulation

    US20160199656A1